TMTM

Aggregate Reporting of Pandemic Influenza Vaccine Doses

Administered Planning for Seasonal Influenza Pilot Test as

Proxy Using CDC's Countermeasure and Response Administration System

Joint Presentation by:

Immunization Services Division

National Center for Immunization and Respiratory Diseases and

Division of Emergency Preparedness and Response

National Center for Public Health Informatics

Webinar Presentation to Public Health Project Areas

June 27, 2007

TMTM

Learning Objectives

• Understand the importance of the seasonal influenza pilot test as a proxy for pandemic influenza vaccine usage tracking

• Understand the data expected and frequency for the pilot

• Understand the expected benefits or lessons learned from the pilot

• Understand the expected challenges for the pilot

• Understand the CDC technical support available for preparing for pilot testing

TMTM

Background• In the event of an influenza pandemic,

timely and complete reporting of Pandemic Influenza vaccine doses administered will allow the Federal Government and Project Areas to closely monitor the use of the vaccine while it is in scarce supply

• CDC and the Project Areas are planning to use a small number of seasonal influenza clinics as proxies for pandemic influenza vaccine administration sites to evaluate technical systems for monitoring pandemic influenza vaccine doses administered

TMTM

Background (continued)• Project Areas will be assessed on their

ability to collect and report to CDC on vaccine doses administered

• CDC will assess the technical capability of the CRA system to receive and aggregate Project Area data

• The goal is to conduct this exercise with minimally invasive impact to normal operations

• This pilot will involve submission of a minimal number of data elements to CDC

TMTM

Why is the Pilot Testing Needed? An Operational Perspective

• To assess ability to collect and report vaccine doses administered data

• To provide perspective on federal, Project Area and clinic needs in order to scale-up for a pandemic situation

• Initial attempt to exercise vaccine tracking plans

• Accomplish timely reporting between key parties

TMTM

Why is the Pilot Testing Needed?A Technical Perspective

• To assess the technical ability of systems to receive, aggregate, and return data

• To identify and address system gaps

• To test tooling options and security aspects for federal and state partners

TMTM

Data Expected by CDC From the Project Area

• Will include (required)• Age• Project Area ID• Date of Clinic(s)

• Will NOT include• Priority Group• Dose Number

TMTM

Reporting Frequency and Timeframe

• Number of Reports and Frequency• If only one clinic site is being used, data from at

least two clinic sessions should be reported using two distinct transmissions

• If more than one clinic site is being used, data from at least one session for each site should be reported using a distinct transmission for each site

• Time Frame• Clinic sessions should occur between November

1 and December 31, 2007• Data from each clinic should be compiled and

transmitted within 48 hours of the clinic session

TMTM

Expected Benefits or Lessons Learned

• Provide a framework for developing future pandemic influenza reporting plans

• Illustrate technical gaps and needs• Identify operational barriers • Understand training needs of staff• Identify equipment needs and capabilities• Gain a preliminary understanding of costs

and other impacts to clinical operations

TMTM

Expected Challenges for Project Area

• Communication and support among all parties

• Availability/distribution of seasonal vaccine

• Technical glitches; training and equipment needs

• Clinic selection and scheduling • Timeliness and completeness of

reporting

TMTM

Expected Challenges for Clinics

• Availability of seasonal vaccine • Reporting not currently required• Timeliness and completeness of

reporting• Data entry staffing, training, and

equipment needs• Communication and support

TMTM

Points of Contact and Resources• Toscha Stanley, Immunization Services Division (ISD),

tstanley@cdc.gov• All POCs have been submitted!!! THANK YOU

• Sanjeeb Sapkota, CRA Team, Division of Emergency Preparedness and Response, ssapkota@cdc.gov or CRAHelp@cdc.gov • Submit option choice by June 30

• CRA Help E-mail CRAHelp@cdc.gov • General aggregate reporting questions and inquiries• Getting access to CRA Exchange, an interactive knowledge

sharing and exchange web site (http://team.cdc.gov/)• PHIN E-mail PHINTech@cdc.gov

• Issuing digital certificates• Getting access to CRA demonstration site• Problem solving

• To get a copy of all presentations and Q and A’s from presentations: http://www.cdc.gov/phin/preparedness/cra.html

TMTM

Questions?

Questions may also be emailed to: CRAHelp@cdc.gov

TMTM

Webinar and Meeting Schedule

• July TBD: Open Q&A and updates on options and pilot test

• August TBD: Open Q&A and updates on options and pilot test